Continued depression of hepatic uroporphyrinogen decarboxylase activity caused by hexachlorobenzene or 2,3,7,8-tetrachlorodibenzo-p-dioxin despite regeneration after partial hepatectomy
- 1 May 1985
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (10) , 1817-1820
- https://doi.org/10.1016/0006-2952(85)90654-9
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Studies on the metabolic fate of [14C]2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the mouseToxicology and Applied Pharmacology, 1984
- Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred miceBiochemical Journal, 1983
- Studies on the toxicology of hexachlorobenzeneArchives of Toxicology, 1983
- Epidemiology of Hexachlorobenzene-Induced Porphyria in TurkeyArchives of Neurology, 1982
- Induction of porphyria in the rat by chronic versus acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxinBiochemical Pharmacology, 1982
- Hepatic toxicity and uroporphyrinogen decarboxylase activity following a single dose of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin to miceBiochemical Pharmacology, 1981
- Drugs and the Hepatic PorphyriasClinics in Haematology, 1980
- The fate of 2,3,7,8-tetrachlorodibenzo-p-dioxin following single and repeated oral doses to the ratToxicology and Applied Pharmacology, 1976
- Acquired Toxic Porphyria Cutanea Tarda Due to HexachlorobenzeneJAMA, 1963
- Cutaneous Porphyria in TurkeyNew England Journal of Medicine, 1960